Risk Sharing Programme

Nearly 90% of all patients become pregnant during our three treatment cycles. If the patient does not become pregnant even during the second cycle of treatment with donor oocytes, we offer the Risk Sharing Programme. 

The success of treatment with donor eggs depends on the quality of formed embryos, and also on the condition of the uterine mucosa (endometrium). Compared to the available results of infertility treatment success in Europe, our clinic stands above the average and ranks among the leading European facilities.

The first and second treatment cycles are fully paid by the patient according to our current price list.

If the third cycle is necessary, the patient pays only half of the current price, and the difference to the full price is paid only if the patient becomes pregnant and foetal heart activity is confirmed by ultrasound examination.
 

We are known in 90 countries of the world.

REPROFIT is one of the top European clinics of reproduction medicine. We always emphasize the quality of care and your comfort. Our best reward are messages from satisfied parents from all over the world.

We speak 8 languages. We will take you through the whole therapeutic cycle. We will settle the necessary administrative aspects with you. We will recommend you accommodation if you wish so. We will always be close to you and helpful.